January 17, 2024Prescriptions for ADHD medications increased significantly during the COVID-19 pandemic, especially for women and for adults aged 20-39, according to a new study published in JAMA Psychiatry.
The most significant increases were found among prescriptions for adults aged 20-39, up 81% for non-stimulants and 30% for stimulants; and for women, up 59% for non-stimulants and 25% for stimulants.1 By contrast, researchers found a decrease or no change in rates of prescriptions during the pandemic for medications used to treat other behavioral health disorders, including anxiety, depression, and opioid use disorders.The researchers, associated with the U.S.
Food and Drug Administration (FDA), sought to explore how the pandemic altered patterns of behavioral health treatment within the U.S.
Read more on additudemag.com